BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29306436)

  • 21. A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide.
    Motabar O; Goldin E; Leister W; Liu K; Southall N; Huang W; Marugan JJ; Sidransky E; Zheng W
    Anal Bioanal Chem; 2012 Jan; 402(2):731-9. PubMed ID: 22033823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Cyclophellitol N-Alkyl and N-Acyl Cyclophellitol Aziridines as Activity-Based Glycosidase Probes.
    Jiang J; Beenakker TJ; Kallemeijn WW; van der Marel GA; van den Elst H; Codée JD; Aerts JM; Overkleeft HS
    Chemistry; 2015 Jul; 21(30):10861-9. PubMed ID: 26073749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease.
    Rudensky B; Paz E; Altarescu G; Raveh D; Elstein D; Zimran A
    Blood Cells Mol Dis; 2003; 30(1):97-9. PubMed ID: 12667991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts.
    Saito M; Rosenberg A
    J Biol Chem; 1985 Feb; 260(4):2295-300. PubMed ID: 3919000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis.
    Gaspar P; Kallemeijn WW; Strijland A; Scheij S; Van Eijk M; Aten J; Overkleeft HS; Balreira A; Zunke F; Schwake M; Sá Miranda C; Aerts JM
    J Lipid Res; 2014 Jan; 55(1):138-45. PubMed ID: 24212238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HEPES-buffering of bicarbonate-containing culture medium perturbs lysosomal glucocerebrosidase activity.
    van der Lienden MJC; Aten J; Boot RG; van Eijk M; Aerts JMFG; Kuo CL
    J Cell Biochem; 2022 May; 123(5):893-905. PubMed ID: 35312102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
    Kohen E; Kohen C; Hirschberg JG; Santus R; Grabowski G; Mangel W; Gatt S; Prince J
    Cell Biochem Funct; 1993 Sep; 11(3):167-77. PubMed ID: 8403230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses.
    Ben Bdira F; Artola M; Overkleeft HS; Ubbink M; Aerts JMFG
    J Lipid Res; 2018 Dec; 59(12):2262-2276. PubMed ID: 30279220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases.
    Ferraz MJ; Marques AR; Appelman MD; Verhoek M; Strijland A; Mirzaian M; Scheij S; Ouairy CM; Lahav D; Wisse P; Overkleeft HS; Boot RG; Aerts JM
    FEBS Lett; 2016 Mar; 590(6):716-25. PubMed ID: 26898341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease.
    Aerts JMFG; Kuo CL; Lelieveld LT; Boer DEC; van der Lienden MJC; Overkleeft HS; Artola M
    Curr Opin Chem Biol; 2019 Dec; 53():204-215. PubMed ID: 31783225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoenzymatic synthesis of 6-phospho-cyclophellitol as a novel probe of 6-phospho-β-glucosidases.
    Kwan DH; Jin Y; Jiang J; Chen HM; Kötzler MP; Overkleeft HS; Davies GJ; Withers SG
    FEBS Lett; 2016 Feb; 590(4):461-8. PubMed ID: 26790390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of broad-specificity activity-based probes for
    McGregor NGS; Kuo CL; Beenakker TJM; Wong CS; Offen WA; Armstrong Z; Florea BI; Codée JDC; Overkleeft HS; Aerts JMFG; Davies GJ
    Org Biomol Chem; 2022 Jan; 20(4):877-886. PubMed ID: 35015006
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.
    Schueler UH; Kolter T; Kaneski CR; Zirzow GC; Sandhoff K; Brady RO
    J Inherit Metab Dis; 2004; 27(5):649-58. PubMed ID: 15669681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D
    Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
    Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
    Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.
    Serra-Vinardell J; Díaz L; Gutiérrez-de Terán H; Sánchez-Ollé G; Bujons J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Grinberg D; Vilageliu L; Casas J
    Int J Biochem Cell Biol; 2014 Sep; 54():245-54. PubMed ID: 25084554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
    Midorikawa M; Okada S; Yutaka T; Yabuuchi H; Naoi M; Kiuchi K; Yagi K
    Biochem Int; 1985 Sep; 11(3):327-32. PubMed ID: 4062951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
    Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
    Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical inhibition of β-glucocerebrosidase does not affect phagocytosis and early containment of Leishmania by murine macrophages.
    Ribeiro H; Rocha MI; Castro H; Macedo MF
    Exp Parasitol; 2020 Sep; 216():107939. PubMed ID: 32535115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended use of dried-leukocytes impregnated in filter paper samples for detection of Pompe, Gaucher, and Morquio A diseases.
    Camelier M; De Mari J; Burin M; Civallero G; Giugliani R
    Clin Chim Acta; 2015 Jun; 446():218-20. PubMed ID: 25944767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.